AAV Contract Development and Manufacturing Organizations Market Growth, Demand and Challenges of the Key Industry Players 2024-32

1
Global AAV Contract Development and Manufacturing
Organizations Market Research and Forecast Report
2024-2032

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• International Market Analysis Research and
  Consulting Group is a leading adviser on
  management strategy and market research
  worldwide. We partner with clients in all regions
  and industry verticals to identify their
  highest-value opportunities, address their most
  critical challenges, and transform their
  businesses.
• IMARCs information products include major
  market, scientific, economic and technological
  developments for business leaders in
  pharmaceutical, industrial, and high technology
  organizations. Market forecasts and industry
  analysis for biotechnology, advanced materials,
  chemicals, food and beverage, travel and tourism,
  nanotechnology and novel processing methods are
  at the top of the companys expertise.
• IMARCs tailored approach combines unfathomable
  insight into the dynamics of companies and
  markets with close cooperation at all levels of
  the client organization. This ensures that our
  clients achieve unmatchable competitive
  advantage, build more proficient organizations,
  and secure lasting results.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled "AAV Contract Development and
  Manufacturing Organizations Market Global
  Industry Trends, Share, Size, Growth, Opportunity
  and Forecast 2024-2032," the global AAV contract
  development and manufacturing organizations
  market size reached US 675.1 Million in 2023.
• Factors Affecting the Growth of the AAV Contract
  Development and Manufacturing Organizations
  Industry
• Advancements in Gene Therapy
• The growing demand for AAV vectors in gene
  therapy delivery is offering a positive market
  outlook. Advancements in gene therapy techniques
  are leading to the development of more
  sophisticated vector designs and delivery
  strategies. AAV development and manufacturing
  organizations (CDMOs) are continually adapting
  their manufacturing processes to accommodate
  these advancements and ensure the production of
  vectors that meet evolving specifications.
• In addition, AAV CDMOs are leveraging
  bioprocessing technologies, such as improved cell
  culture systems, purification methods, and
  analytics, to streamline production workflows and
  increase yield while maintaining product quality
  and consistency.

4
Report Highlight and Description

• Outsourcing Trend
• The rising focus on outsourcing AAV vector
  manufacturing is bolstering the market growth. In
  addition, biopharmaceutical companies are
  leveraging the capabilities of AAV CDMOs to
  mitigate risks, accelerate production timelines,
  and allocate resources more efficiently.
• By outsourcing, firms can access advanced
  manufacturing technologies and ensure compliance
  with regulatory standards without capital
  investment. This trend underscores the strategic
  advantage of partnering with specialized CDMOs,
  enabling pharmaceutical companies to focus on
  core competencies while benefiting from the
  specialized capabilities offered by AAV CDMOs.
• Technological Advancements
• Innovations in AAV vector production,
  purification, and analytics are impelling the
  market growth. Advanced technologies enhance
  manufacturing efficiency, scalability, and
  product quality, meeting the increasing demands
  of gene therapy developers. Besides this, CDMOs
  are investing in novel platforms and processes to
  gain a competitive edge and attract clients
  seeking advanced manufacturing solutions.

5
Report Highlight and Description

• Furthermore, modular bioprocessing systems enable
  AAV CDMOs to customize manufacturing workflows,
  optimize resource utilization, and expedite
  process development and scale-up. These platforms
  facilitate cost-effective manufacturing
  solutions, empowering AAV CDMOs to meet the
  evolving demands of gene therapy.
• Request for a PDF sample of this report
  https//www.imarcgroup.com/aav-contract-developmen
  t-manufacturing-organizations-market/requestsample

6
Report Description

• Global AAV Contract Development and Manufacturing
  Organizations Market Trends
• The growing demand for AAV CDMO services due to
  the expanding pipeline of gene therapy candidates
  across therapeutic domains like rare diseases and
  oncology is positively influencing the market. In
  addition, biopharmaceutical companies are
  increasingly seeking specialized expertise and
  scalable manufacturing solutions from CDMOs to
  expedite product development and
  commercialization.
• Besides this, the rising investment in
  outsourcing partnerships to efficiently navigate
  the complexities of AAV vector production and
  purification is bolstering the market growth.
  Furthermore, collaborations and partnerships
  between AAV CDMOs and biopharmaceutical companies
  assist in accelerating product development and
  commercialization.
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/aav-contract-developmen
  t-manufacturing-organizations-market

7
Report Segmentation

• Breakup by Workflow
• Upstream Processing
• Downstream Processing
• Breakup by Culture Type
• Adherent Culture
• Suspension Culture
• Breakup by Application
• Cell and Gene Therapy Development
• Vaccine Development
• Biopharmaceutical and Pharmaceutical Discovery
• Biomedical Research

8
Report Segmentation

• Breakup by End User
• Pharmaceutical and Biopharmaceutical Companies
• Academic and Research Institutes
• Breakup by Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

9
Competitive Landscape with Key Players

• ABL Manufacturing (Institut Mérieux)
• Asklepios BioPharmaceutical Inc. (Bayer AG)
• Anlongbio
• Belief Biome Inc.
• Catalent Inc.
• Charles River Laboratories International Inc.
• Creative Biogene
• GenScript ProBio (GenScript Biotech Corporation)
• Merck KGaA
• Oxford Biomedica
• TFBS Bioscience Inc.
• Thermo Fischer Scientific Inc.

10
Key Questions Answered in the Report
11
Key Questions Answered in the Report
12
Table of Contents

• 1    Preface2 Scope and Methodology
• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
• 2.3.1 Primary Sources
• 2.3.2 Secondary Sources
• 2.4 Market Estimation
• 2.4.1 Bottom-Up Approach
• 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology
• 3 Executive Summary
• 4 Global AAV Contract Development And
  Manufacturing Organizations Market - Introduction
• 4.1 Overview
• 4.2 Market Dynamics
• 4.3 Industry Trends
• 4.4 Competitive Intelligence
• 5 Global AAV Contract Development And
  Manufacturing Organizations Market Landscape
• 5.1 Historical and Current Market Trends
  (2018-2023)
• 5.2 Market Forecast (2024-2032)

13
Table of Contents

• 6.2 Downstream Processing
• 6.2.1 Overview
• 6.2.2 Historical and Current Market Trends
  (2018-2023)
• 6.2.3 Market Segmentation
• 6.2.3.1 Purification
• 6.2.3.2 Fill Finish
• 6.2.4 Market Forecast (2024-2032)
• 6.3 Attractive Investment Proposition by Workflow
• 7 Global AAV Contract Development And
  Manufacturing Organizations Market - Breakup by
  Culture Type
• 7.1 Adherent Culture
• 7.1.1 Overview
• 7.1.2 Historical and Current Market Trends
  (2018-2023)
• 7.1.3 Market Segmentation
• 7.1.4 Market Forecast (2024-2032)
• 7.2 Suspension Culture
• 7.2.1 Overview
• 7.2.2 Historical and Current Market Trends
  (2018-2023)
• 7.2.3 Market Segmentation
• 7.2.3.1 Chemistry Analyzers

14
Partial List of Clients
15
Partial List of Clients
16
Disclaimer

• 2024 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

17
Contact Us
Visit us at
https//www.imarcgroup.com
1-631-791-1145
sales_at_imarcgroup.com
Stay With Us